van der Horst Edward 4
4 · Sensei Biotherapeutics, Inc. · Filed Feb 16, 2024
Insider Transaction Report
Form 4
van der Horst Edward
CHIEF SCIENTIFIC OFFICER
Transactions
- Award
Stock Option (Right to Buy)
2024-02-15+125,000→ 125,000 totalExercise: $0.79Exp: 2034-02-14→ Common Stock (125,000 underlying) - Tax Payment
Common Stock
2024-02-15$0.79/sh−2,843$2,246→ 56,070 total - Award
Stock Option (Right to Buy)
2024-02-15+90,102→ 90,102 totalExercise: $0.79Exp: 2034-02-14→ Common Stock (90,102 underlying)
Footnotes (4)
- [F1]Represents shares withheld to satisfy withholding tax obligations upon the vesting of restricted stock units.
- [F2]Includes an aggregate of 6,000 shares purchased by the Reporting Person since May 16, 2023 pursuant to the Issuer's 2021 Employee Stock Purchase Plan.
- [F3]The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 15, 2025, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
- [F4]Represents one-third of the Reporting Person's 2023 annual bonus, which the Compensation Committee of the Issuer determined to pay in the form of a stock option in lieu of cash. 100% of the shares are fully vested as of the date of grant.